Abstract:MicroRNAs (miRs) are endogenously expressed small noncoding RNA molecules that are able to regulate gene expression on the posttranscriptional level by binding to the mRNAs of their target genes, thus inducing inhibition of translation or mRNA degradation. The miR-17–92 cluster (encoding miR-17, -18a, -19a, -20a, -19b and miR-92a) was shown to augment tumor angiogenesis if overexpressed in tumor cells. Whereas miR-92a was recently identified as negative regulator of vessel growth, the individual functions of the other members of the miR-17–92 cluster in endothelial cells is less clear and only a combination of miR-17, -18a and -20a was shown to partially rescue the defective angiogenesis under conditions of Dicer deficiency. To investigate the involvement of the individual members of the miR-17–92 cluster in angiogenesis, human umbilical vein endothelial cells (HUVECs) were transfected with precursor molecules for miR-17, -18a, -19a and -20a. Overexpression of the different members significantly inhibited 3D spheroid sprouting (Pre-17:10±3%,-18a: 28±5%,-19a: 45±4%,-20a: 33±8% of control) and impaired the assembly of capillary networks in vitro. Conversely, inhibition of miR-17 (142±15% of control), miR-18a (152±6% of control) and miR-20a (153±9% of control) augmented spheroid sprout formation. Next, we addressed the in vivo relevance by using antagomirs to block the individual miRs. Antagomir-17 (which also blocks miR-20a) significantly increased the number of lectin-positive vessels in matrigel plugs (190±26% of control), whereas antagomirs, which specifically affect miR-18a and miR-19a were less effective. Antagomir-17 additionally improved blood flow after hind limb ischemia (217±24% of control) and increased tumor growth (140±14% of control). To identify direct targets of miR-17, we combined microarray gene expression analysis with target prediction. Among others, Janus kinase 1 (Jak1) was significantly downregulated on mRNA (38±5% of control) and protein (41±14% of control) level by miR-17. In summary, we show that the individual members of the miR-17–92 clusters exhibit a cell intrinsic anti-angiogenic activity in endothelial cells. Inhibition of miR-17 efficiently increased neovascularization and tumor growth in vivo.

The Human Myoepithelial Cell Displays a Multifaceted Anti-Angiogenic Phenotype

The Human Myoepithelial Cell Is A Natural Tumor Suppressor

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

Three-dimensional human leiomyoma xenografts induce angiogenesis by inducing hypoxia inducible factor-1 alpha

Autocrine Human Growth Hormone Promotes Tumor Angiogenesis in Mammary Carcinoma

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment

Observation Of Incipient Tumor Angiogenesis That Is Independent Of Hypoxia And Hypoxia Inducible Factor-1 Activation

Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer

Identification of an angiogenic mitogen selective for endocrine gland endothelium

Attenuating Epithelial‐to‐Mesenchymal Transition in Cancer through Angiopoietin‐Like 4 Inhibition in a 3D Tumor Microenvironment Model

Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels

Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target

Mesenchymal Stem Cell-Derived Angiogenin Promotes Primodial Follicle Survival and Angiogenesis in Transplanted Human Ovarian Tissue

Tumor Cell-Secreted Angiogenin Induces Angiogenic Activity of Endothelial Cells by Suppressing Mir-542-3p

Expression and Epigenetic Regulation of Angiogenesis-Related Factors During Dormancy and Recurrent Growth of Ovarian Carcinoma

Abstract 5756: The MicroRNA-17–92 Cluster Exhibits a Cell Intrinsic Anti-angiogenic Function in Endothelial Cells

Increased PD-L1 Expression and IL-6 Secretion Characterize Human Lung Tumor-Derived Perivascular-Like Cells That Promote Vascular Leakage in a Perfusable Microvasculature Model.

Tamoxifen Enhances Myoepithelial Cell Suppression of Human Breast Carcinoma Progression in Vitro by Two Different Effector Mechanisms

Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells.

Cancer apelin receptor suppresses vascular mimicry in malignant melanoma

Data from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment